Clinical Trials Browser

Phase 2 × Stomach Neoplasms × trebananib × Clear all

NCT00583674 2014-05-07

Phase 2 Study of AMG 386 (20060439) in Combination With Cisplatin & Capecitabine in Subjects With Metastatic Gastric, Gastroesophageal Junction, or Distal Esophageal Adenocarcinoma

Phase 2 Completed

Gastrointestinal

Gastrointestinal Neoplasms, Stomach Neoplasms